These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24563103)

  • 1. Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen.
    Barclay JS; Owens JE; Blackhall LJ
    Support Care Cancer; 2014 Jul; 22(7):1883-8. PubMed ID: 24563103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine drug screen findings among ambulatory oncology patients in a supportive care clinic.
    Rauenzahn S; Sima A; Cassel B; Noreika D; Gomez TH; Ryan L; Wolf CE; Legakis L; Del Fabbro E
    Support Care Cancer; 2017 Jun; 25(6):1859-1864. PubMed ID: 28120116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy.
    Katz NP; Sherburne S; Beach M; Rose RJ; Vielguth J; Bradley J; Fanciullo GJ
    Anesth Analg; 2003 Oct; 97(4):1097-1102. PubMed ID: 14500164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study.
    Ives TJ; Chelminski PR; Hammett-Stabler CA; Malone RM; Perhac JS; Potisek NM; Shilliday BB; DeWalt DA; Pignone MP
    BMC Health Serv Res; 2006 Apr; 6():46. PubMed ID: 16595013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic.
    Arthur JA; Edwards T; Lu Z; Reddy S; Hui D; Wu J; Liu D; Williams JL; Bruera E
    Cancer; 2016 Dec; 122(23):3732-3739. PubMed ID: 27509305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.
    Argoff CE; Alford DP; Fudin J; Adler JA; Bair MJ; Dart RC; Gandolfi R; McCarberg BH; Stanos SP; Gudin JA; Polomano RC; Webster LR
    Pain Med; 2018 Jan; 19(1):97-117. PubMed ID: 29206984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do Palliative Care Clinics Screen for Substance Abuse and Diversion? Results of a National Survey.
    Tan PD; Barclay JS; Blackhall LJ
    J Palliat Med; 2015 Sep; 18(9):752-7. PubMed ID: 26302425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
    Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L
    Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?
    Manchikanti L; Manchukonda R; Pampati V; Damron KS; Brandon DE; Cash KA; McManus CD
    Pain Physician; 2006 Apr; 9(2):123-9. PubMed ID: 16703972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients.
    Manchikanti L; Giordano J; Boswell MV; Fellows B; Manchukonda R; Pampati V
    J Opioid Manag; 2007; 3(2):89-100. PubMed ID: 17520988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.
    Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N
    J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substance abuse in cancer pain.
    Starr TD; Rogak LJ; Passik SD
    Curr Pain Headache Rep; 2010 Aug; 14(4):268-75. PubMed ID: 20499215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and Assessment of Substance Use in Hospice Care: Examining Content from a National Sample of Psychosocial Assessments.
    Sacco P; Cagle JG; Moreland ML; Camlin EAS
    J Palliat Med; 2017 Aug; 20(8):850-856. PubMed ID: 28333571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for substance abuse and diversion in Virginia hospices.
    Blackhall LJ; Alfson ED; Barclay JS
    J Palliat Med; 2013 Mar; 16(3):237-42. PubMed ID: 23289944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.